Advisor Group Holdings, Inc. Graphite Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$2.24 - $2.66 $2,956 - $3,511	-1,320 Reduced 49.62%	1,340 $3,000
Q3 2023 Nov 13, 2023	BUY	$2.18 - $2.77 $2,877 - $3,656	1,320 Added 98.51%	2,660 $6,000
Q2 2023 Aug 10, 2023	SELL	$2.47 - $3.38 $4,322 - $5,915	-1,750 Reduced 56.63%	1,340 $3,000
Q4 2022 Feb 10, 2023	BUY	$2.82 - $3.59 $56 - $71	20 Added 0.65%	3,090 $10,000
Q2 2022 Aug 10, 2022	BUY	$2.14 - $5.23 $3,745 - $9,152	1,750 Added 132.58%	3,070 $9,000
Q3 2021 Nov 05, 2021	BUY	$15.81 - $28.39 $20,869 - $37,474	1,320 New	1,320 $22,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.